13 research outputs found
Women’s experiences of wearing therapeutic footwear in three European countries
Background: Therapeutic footwear is recommended for those people with severe foot problems associated with
rheumatoid arthritis (RA). However, it is known that many do not wear them. Although previous European studies
have recommended service and footwear design improvements, it is not known if services have improved or if this
footwear meets the personal needs of people with RA. As an earlier study found that this footwear has more
impact on women than males, this study explores women’s experiences of the process of being provided with it
and wearing it. No previous work has compared women’s experiences of this footwear in different countries,
therefore this study aimed to explore the potential differences between the UK, the Netherlands and Spain.
Method: Women with RA and experience of wearing therapeutic footwear were purposively recruited. Ten women
with RA were interviewed in each of the three countries. An interpretive phenomenological approach (IPA) was
adopted during data collection and analysis. Conversational style interviews were used to collect the data.
Results: Six themes were identified: feet being visibly different because of RA; the referring practitioners’ approach
to the patient; the dispensing practitioners’ approach to the patient; the footwear being visible as different to
others; footwear influencing social participation; and the women’s wishes for improved footwear services. Despite
their nationality, these women revealed that therapeutic footwear invokes emotions of sadness, shame and anger
and that it is often the final and symbolic marker of the effects of RA on self perception and their changed lives.
This results in severe restriction of important activities, particularly those involving social participation. However,
where a patient focussed approach was used, particularly by the practitioners in Spain and the Netherlands, the
acceptance of this footwear was much more evident and there was less wastage as a result of the footwear being
prescribed and then not worn. In the UK, the women were more likely to passively accept the footwear with the
only choice being to reject it once it had been provided. All the women were vocal about what would improve
their experiences and this centred on the consultation with both the referring practitioner and the practitioner that
provides the footwear.
Conclusion: This unique study, carried out in three countries has revealed emotive and personal accounts of what
it is like to have an item of clothing replaced with an ‘intervention’. The participant’s experience of their
consultations with practitioners has revealed the tension between the practitioners’ requirements and the women’s
‘social’ needs. Practitioners need greater understanding of the social and emotional consequences of using
therapeutic footwear as an intervention
A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)
Meeting abstrac
Hera: Development of Semantic Web Information Systems
As a consequence of the success of the Web, methodologies for information system development need to consider systems that use the Web paradigm. These We
Automatization and improvement of μCT analysis for murine lung disease models using a deep learning approach
Optimal mean airway pressure during high-frequency oscillatory ventilation in an experimental model of acute respiratory distress syndrome: EIT-based method
High-frequency oscillatory ventilation guided by transpulmonary pressure in acute respiratory syndrome: an experimental study in pigs
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss
Neglected Tropical Diseases of Oceania: Review of Their Prevalence, Distribution, and Opportunities for Control
Among Oceania's population of 35 million people, the greatest number living in poverty currently live in Papua New Guinea (PNG), Fiji, Vanuatu, and the Solomon Islands. These impoverished populations are at high risk for selected NTDs, including Necator americanus hookworm infection, strongyloidiasis, lymphatic filariasis (LF), balantidiasis, yaws, trachoma, leprosy, and scabies, in addition to outbreaks of dengue and other arboviral infections including Japanese encephalitis virus infection. PNG stands out for having the largest number of cases and highest prevalence for most of these NTDs. However, Australia's Aboriginal population also suffers from a range of significant NTDs. Through the Pacific Programme to Eliminate Lymphatic Filariasis, enormous strides have been made in eliminating LF in Oceania through programs of mass drug administration (MDA), although LF remains widespread in PNG. There are opportunities to scale up MDA for PNG's major NTDs, which could be accomplished through an integrated package that combines albendazole, ivermectin, diethylcarbamazine, and azithromycin, in a program of national control. Australia's Aboriginal population may benefit from appropriately integrated MDA into primary health care systems. Several emerging viral NTDs remain important threats to the region
Arboviruses of Oceania
Arboviruses present an ongoing challenge to Oceanic nations. Viruses including Ross River, Barmah Forest and Murray Valley encephalitis are endemic to the region and are responsible for occasional outbreaks. Recent epidemics of chikungunya, Zika and dengue viruses across many nations demonstrate the vulnerability of this region to globally emergent arboviruses. In addition to global disease trends, the emergence of these viruses is largely driven by human influences such as water and waste management, air travel and land use. Limited public health resources and infrastructure, dispersed populations and the complexity of arbovirus ecologies complicate mitigation and management strategies in the Western Pacific. A regional collaborative approach augments the surveillance and response capability of individual nations, but the challenge of managing arbovirus risk with limited resources remains. In the absence of specific disease treatments and feasible vaccination solutions, mosquito control and personal protective measures are the mainstay of management programmes, albeit with variable success. In the long term, the development and integration of novel surveillance, diagnostic and mosquito control technologies will improve the capacity to prevent and respond to arbovirus threats